Cite
MLA Citation
S. Ferrero et al.. “FIRST APPLICATION OF MINIMAL RESIDUAL DISEASE ANALYSIS IN SPLENIC MARGINAL ZONE LYMPHOMA TRIALS: PRELIMINARY RESULTS FROM BRISMA/IELSG36 PHASE II STUDY.” Hematological oncology, vol. 37, n.d., pp. 224–225. http://access.bl.uk/ark:/81055/vdc_100086210627.0x000042